BPC-157 + TB-500 Blend 5mg / 5mg

 89,00

BPC-157 / TB-500 Blend 5 mg / 5 mg – Grail Formula Quality.
Researched and verified with Liquilabs s.r.o. Czechia.
Analytical testing confirms verified peptide content with BPC-157 at 6.17 mg and TB-500 at 6.39 mg, endotoxin levels below 0.001 EU/mg and no detectable microbial contamination or heavy metals.
Supplied as a dual-peptide lyophilized research blend with full COA traceability.
Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.
For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview This BPC-157 / TB-500 research blend combines two extensively studied peptides used in laboratory research focused on tissue integrity, cellular repair signalling and regenerative pathway modelling. Each vial contains a dual-peptide formulation designed for controlled in-vitro research applications requiring combined peptide interaction analysis.   Peptide Overview BPC-157 (Body Protection Compound) is a pentadecapeptide fragment derived from a larger gastric protein, first studied extensively between 1990 and 2010 in research examining tissue stability and cellular repair signalling. TB-500 (Thymosin Beta 4) is a synthetic analogue of the naturally occurring thymosin beta peptide, researched since the 1980s for its involvement in actin-binding, cytoskeletal organisation and cellular migration models.   Historical Background and Scientific Context Research into peptide-mediated tissue signalling expanded significantly between 1980 and 2000, with thymosin beta peptides forming a core focus in cytoskeletal and regenerative research. From 2000 onward, BPC-157 gained prominence in laboratory models investigating gastrointestinal integrity, connective tissue signalling and regulated cellular repair mechanisms. Between 2015 and 2025 combined peptide research increased, with dual-peptide blends such as BPC-157 and TB-500 used in experimental models exploring synergistic signalling behaviour under controlled laboratory conditions.   Structural & Molecular Characteristics • BPC-157 chain length: 15 amino acids • TB-500 (Thymosin Beta 4) chain length: 43 amino acids • Peptide classification: linear synthetic research peptides • Functional domains: tissue signalling, actin-binding and cellular repair pathways • Formulation type: dual-peptide research blend   Mechanistic Focus in Research
  • Tissue repair and cellular regeneration pathway modelling
  • Cytoskeletal organisation and actin-binding studies
  • Peptide synergy and combined signalling research
  • Structure–function analysis of regenerative peptides
  • Controlled in-vitro biochemical experimentation
  Analytical Verification (COA) Independent laboratory analysis performed by Liquilabs s.r.o. (Czechia) confirms full analytical validation for this batch. BPC-157 assay content was verified at 6.17 mg and Thymosin Beta 4 (TB-500) assay content was verified at 6.39 mg. Bacterial endotoxin levels were confirmed below 0.001 EU/mg. Total aerobic microbial count and total yeast and mold count were not detected. Heavy metals were not detected, including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium. Peptide identity was confirmed by chromatographic retention time and spectral validation.  

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use
  • Independently analysed by Liquilabs s.r.o. Czechia
  • BPC-157 assay content verified at 6.17 mg
  • TB-500 assay content verified at 6.39 mg
  • Endotoxin level below 0.001 EU/mg
  • No detectable microbial contamination
  • No detectable heavy metals
  • Dual-peptide research blend for regenerative studies
  • EU shipments include bacteriostatic water
  • For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products